Ruchi Gupta
Company: Pendulum Therapeutics
Job title: Vice President, Head of R&D
Seminars:
Chair’s Opening Remarks 8:50 am
day: Day Two
Panel Discussion: Defining the Therapeutic Windows of Drugs to Ensure Patient Safety Whilst Maintaining Drug Efficacy 9:50 am
Balancing the therapeutic index versus safety in targeting complement Discussing this in the context of disease versus healthy complement inhibition Reviewing the therapeutic window when you target classical, lectin or alternative pathways Discussing pharmacokinetics of targeting complement Specifying inclusion/exclusion criteria put in place specifically due to safety considerations e.g. avoiding comorbidities or infectionsRead more
day: Day One